Please login to the form below
Why pharma should invest in the education of doctors
By Tim Russell, Heather Hancock and Deepak Jadon
Three steps forward, four steps back
How to ensure digital content achieves the right dialogue
Weirdos and misfits
Can diversity improve engagement in healthcare?
We’ll need more than a spoonful of sugar to counter vaccine hesitancy
By Satinder Phull
Rare diseases: redefining medical communications
By Ian Keary
-
The dawn of a new era in medical educationBy Annlouise Pendse
-
The power of high-value, highly relevant content to support clinical decisionsby Sandrine Veillet
-
A new era in European Parliament: policymakers need to hear from pharma by Nick Hoile
-
Transitions in healthcareBy Dr Jonathan Reston
-
Evolving behaviour changeBy Paul Tanner
-
Crossing the digital divide between big pharma and real-world patientsCan pharma harness the digital world?
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- Sinovac reveals positive preliminary data for COVID-19 vaccine
- Britain closes in on £500m COVID-19 vaccine deal with Sanofi/GSK
- FDA approves Roche’s Actemra COVID-19 trial
- The best work in healthcare communications shines at virtual Communiqué Awards
- Mesoblast expands compassionate use COVID-19 programme
- Lucid Group: Digital Delivery in Lockdown
- Live Webinar: The update of digital technologies in healthcare
- Live Webinar: Accelerating the Digital Health Economy through Innovation
- Last chance to register - Webinar: How to price a pharmaceutical product during a global economic recession
- Porterhouse Medical Group – proud to be part of the first virtual Communiqué Awards 2020
- GSK signs deal with Medicago for COVID-19 vaccine
PMHub
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...
Latest intelligence
- A snapshot of… Exscientia
- ...
- Patients are ready for virtual clinical trials, are you?
- Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...
- Keep your audiences close
- How getting up close and personal with target audiences can fuel creativity...
Quick links
Infographics
